{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:14:51Z","timestamp":1790115291355,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.atherosclerosis.2019.09.006","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T23:50:11Z","timestamp":1568332211000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989\u20132017"],"prefix":"10.1016","volume":"290","author":[{"given":"Alison","family":"Pottle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Barbir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Bayly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaimini","family":"Cegla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cramb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Eatough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Neuwirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handrean","family":"Soran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahenaz","family":"Walji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Weedon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dev Borunendra","family":"Nath Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib1","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(81)91213-7","article-title":"Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia","volume":"2","author":"Stoffel","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1567-5688(09)71805-7","article-title":"LDL-Apheresis in homozygous LDL-receptor-defective familial hypercholesterolemia: the Munich experience","volume":"10","author":"Keller","year":"2009","journal-title":"Atherosclerosis Suppl."},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9150(98)00328-1","article-title":"Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS)","volume":"144","author":"Nishimura","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib4","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0002-9149(98)00692-4","article-title":"Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia","volume":"82","author":"Mabuchi","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.atherosclerosissup.2015.02.012","article-title":"Lipoprotein apheresis for Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease \u2013 additional particular aspects of the Pro(a)LiFe multicentre trial","volume":"18","author":"Klingel","year":"2015","journal-title":"Atherosclerosis Suppl."},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2019.09.006_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11789-017-0089-9","article-title":"The German lipoprotein apheresis registry (GLAR) \u2013 almost 5 years on","volume":"12","author":"Schettler","year":"2017","journal-title":"Clin Res Cardiol Suppl"},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib7","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/eurheartj\/ehx317","article-title":"Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol","volume":"39","author":"Thompson","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib8","series-title":"Idenitification and Management of Familial Hypercholesterolaemia","author":"National Institute for Health and Care Excellence","year":"2008"},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.atherosclerosis.2008.02.009","article-title":"Recommendations for the use of LDL apheresis","volume":"198","author":"Thompson","year":"2008","journal-title":"Atherosclerosis"},{"issue":"2016","key":"10.1016\/j.atherosclerosis.2019.09.006_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","volume":"253","author":"Catapano","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib11","author":"France"},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.atherosclerosis.2009.06.010","article-title":"Efficacy criteria and cholesterol targets for LDL apheresis","volume":"208","author":"Thompson","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib13","first-page":"1561","article-title":"Apheresis as a novel treatment for refractory angina with raised lipoprotein (a): a randomised controlled cross-over trial","volume":"38","author":"Khan","year":"2017","journal-title":"Eur. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib14","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(69)90930-1","article-title":"Risks of ischaemic heart-disease in familial hyperlipoproteinaemia states","volume":"2","author":"Slack","year":"1969","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.09.006_bib15","doi-asserted-by":"crossref","first-page":"84e85","DOI":"10.1136\/hrt.76.1.84","article-title":"Aortic stenosis in homozygous familial hypercholesterolaemia","volume":"76","author":"Rallidis","year":"1996","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2019.09.006_bib16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MOL.0b013e32833c14e2","article-title":"Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia","volume":"21","author":"Datta","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2018.01.034","article-title":"A nation-wide survey of patients with homozygous familial hypercholesterolaemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)","volume":"270","author":"Kayikcioglu","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib18","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jacl.2011.04.001","article-title":"Management of familial hypercholesterolaemias in adult patients: recommendations from the national lipid association expert panel on familial hypercholesterolaemia","volume":"5","author":"Ito","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib19","unstructured":"Forms of therapeutic hemopheresis. Summary report of the Working Party on Medical Treatment of the Federal Committee of Physicians and Health Insurance Companies on the Deliberations Pursuant to \u00a7 135 para 1 of the Code of Social Law 2009, vol vol. V ((SGB V))."},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosissup.2015.02.033","article-title":"Effects of lipoprotein apheresis on the lipoprotein (a) levels in the long run","volume":"18","author":"Gro\u03b2","year":"2015","journal-title":"Atherosclerosis Suppl."},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.transci.2016.12.024","article-title":"The Italian registry of therapeutic apheresis \u2013 2015","volume":"56","author":"De Silvestro","year":"2017","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/14779072.6.5.629","article-title":"Comparison of different LDL apheresis methods","volume":"6","author":"Julius","year":"2008","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jca.20215","article-title":"Homozygous familial hypercholesterolemia: long term clinical course and plasma exchange therapy for two individual patients and review of the literature","volume":"24","author":"Beigel","year":"2009","journal-title":"J. Clin. Apher."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2019.09.006_bib24","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1681\/ASN.2016040412","article-title":"Complications of the arteriovenous fistula: a systematic review","volume":"28","author":"Al-Jaishi","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib25","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER steering committee. Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"NEJM"},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib26","article-title":"ODYSSEY OUTCOMES committees and investigators. Patients with recent acute coronary syndrome and polyvascular disease derive large absolute benefit from alirocumab: ODYSSEY OUTCOMES trial","author":"Jukema","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2019.09.006_bib27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S2213-8587(17)30044-X","article-title":"Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study","volume":"5","author":"Raal","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13023-018-0841-3","article-title":"Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia","volume":"13","author":"Blom","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib29","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehy334","article-title":"Cardiovascular disease risk associated with elevated lipoprotein (a) attenuates at low-density lipoprotein cholesterol levels in a primary prevention setting","author":"Verbeek","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2018.1470","article-title":"Association of LPA variants with risk of coronary disease and the implications for lipoprotein (a)-lowering therapies: a Mendelian randomization analysis","author":"Burgess","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2019.09.006_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jacl.2012.03.004","article-title":"Apheresis in homozygous familial hypercholesterolaemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolaemia","volume":"6","author":"Gr\u00e6sdal","year":"2012","journal-title":"J Clin Lipidol"}],"updated-by":[{"DOI":"10.1016\/j.atherosclerosis.2019.12.015","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000}}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019314807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019314807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T09:15:57Z","timestamp":1579252557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019314807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":32,"alternative-id":["S0021915019314807"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.09.006","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.atherosclerosis.2019.12.015","asserted-by":"object"}]},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989\u20132017","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}